Intervention
blood draw
ClinicalTrials.gov intervention label
Clinical trials
21 shownUnderstanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle MassNCT07132788 · 2025-05-01
RECRUITINGUtilizing Long-read Sequencing to Investigate the EGFR Landscape of EGFR Positive Lung Cancer PatientsNCT06659458 · 2025-01-01
RECRUITINGA Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryNCT06127979 · 2024-08-30
RECRUITINGClinical Validation of Freenome Multiomics Blood Test for Lung Cancer ScreeningNCT06122077 · 2023-11-28
RECRUITINGLiver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)NCT03403686 · 2018-01-11
RECRUITINGImmune Function and the Progression to T1DNCT05899439 · 2005-01-01
RECRUITINGUnderstanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and NeuroimagingNCT07474779 · 2026-05-11
NOT_YET_RECRUITINGPROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).NCT05602259 · 2022-10-27
UNKNOWNAtlas of Retinal Imaging in Alzheimer's StudyNCT03862222 · 2019-12-16
COMPLETEDSysmex-XN 20 Analyser to Assess Lymphocyte Subsets and Other Haematological Parameters in Chronic/Acute Viral InfectionsNCT03495570 · 2018-04-15
UNKNOWNAnalysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV PatientsNCT03244371 · 2016-08-31
UNKNOWNAnalysis of Cell-free DNA (cfDNA) in Men With Elevated PSA LevelsNCT02771769 · 2016-01-01
TERMINATEDLongitudinal Evaluation of HIV-associated Lung Disease PhenotypesNCT02238327 · 2014-09-01
COMPLETEDEvaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical RecurrenceNCT02070575 · 2014-02-20
COMPLETEDMechanisms of Immunosurveillance for Lung CancerNCT01710319 · 2012-09-01
COMPLETEDApoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)NCT01099410 · 2010-02-01
COMPLETEDParkinson's Disease Genetics DatabaseNCT00855556 · 2008-02-01
TERMINATEDPK of Once Daily ART Containing Tenofovir and Atazanavir/RitonavirNCT00273273 · 2006-02-01
COMPLETEDChanges in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseNCT00281242 · 2005-09-01
COMPLETEDmiRNA (microRNA) and FGF21 (Fibroblast Growth Factor-21) Profile in First Trimester and Gestational Diabetes PredictionNCT05632055 · 2000-08-26
ACTIVE_NOT_RECRUITINGViral and Host Factors in the Transmission and Pathogenesis of HIVNCT00219947 · 2000-07-01
TERMINATEDCommon conditions
Chronic Obstructive Pulmonary Disease2HIV Infections2Aging1Alzheimer Disease1Breast Cancer1Chronic Hepatitis C1Chronic HIV Infection1Chronic Viral Hepatitis B1Cognitive Change1Diabetic Retinopathy1Diagnostic1EGFR Exon 19 Deletion Mutation1Emphysema1GBA1 Parkinson Disease1Gestational Diabetes1HIV1HIV Associated HCV1Lung Cancer1Lung Cancer - Non Small Cell1Lung Cancer Diagnosis1Lung Diseases, Obstructive1Mild Cognitive Impairment1Mild Dementia1Non-small Cell Lung Cancer1Parkinson's Disease1
Leading sponsors
Memorial Sloan Kettering Cancer Center2Assistance Publique Hopitaux De Marseille1Centre Hospitalier Universitaire de Liege1Chiang Mai University1Chronix Biomedical Corporation1Freenome Holdings Inc.1Northwell Health1Our Lady of the Lake Hospital1Rockefeller University1University College, London1University of Alabama at Birmingham1University of Florida1University of Michigan1University of North Carolina, Chapel Hill1University of Pavia1
Trial status mix
COMPLETED7
RECRUITING6
TERMINATED3
UNKNOWN3
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
Phase mix
NA4
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.